Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001839882-25-007658
Filing Date
2025-02-06
Accepted
2025-02-06 16:16:23
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 5269
  Complete submission text file 0001839882-25-007658.txt   7002
Mailing Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660
Business Address 520 NEWPORT CENTER DRIVE SUITE 1200 NEWPORT BEACH CA 92660 (949) 284-4555
Evolus, Inc. (Subject) CIK: 0001570562 (see all company filings)

EIN.: 461385614 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-90861 | Film No.: 25597594
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 78, GANGNI 1-GIL, OCHANG-EUP, CHEONGWON-GU CHEOGJU-SI M5 28126
Business Address 78, GANGNI 1-GIL, OCHANG-EUP, CHEONGWON-GU CHEOGJU-SI M5 28126 82-2-3471-8319
Medytox Inc. (Filed by) CIK: 0001848514 (see all company filings)

EIN.: 000000000 | State of Incorp.: M5 | Fiscal Year End: 1220
Type: SCHEDULE 13G/A